ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,121Medicare Part D Prescriptions Filled, Including Refills

Rank: 401 out of 3001

$472K Total Retail Price of All Prescriptions

Rank: 721 out of 3001

290 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

36% of this provider’s 290 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

7% of this provider’s 290 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 10,018 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
NAMENDA 463 463 1 40
FUROSEMIDE 417 414 2 6
SERTRALINE HCL 336 334 3 20
LEVOTHYROXINE SODIUM 333 333 4 3
POTASSIUM CHLORIDE 316 315 5 15
LISINOPRIL 313 311 6 2
AMLODIPINE BESYLATE 279 277 7 5
METOPROLOL TARTRATE 267 265 8 8
DONEPEZIL HCL 249 249 9 27
JANTOVEN 219 219 10 110
TRAMADOL HCL 212 209 11 17
MIRTAZAPINE 211 211 12 44
OMEPRAZOLE 199 198 13 4
WARFARIN SODIUM 194 193 14 12
POLYETHYLENE GLYCOL 3350 167 167 15 55
SIMVASTATIN 165 164 16 1
FAMOTIDINE 143 139 17 68
ALBUTEROL SULFATE 128 128 18 99
OXYCODONE-ACETAMINOPHEN 127 120 S2 19 32
EXELON 122 122 20 108
METFORMIN HCL 122 121 20 9
RISPERIDONE 121 121 22 63
HYDROCODONE-ACETAMINOPHEN 117 116 S3 23 7
DIVALPROEX SODIUM 103 103 24 70
TRAZODONE HCL 95 93 25 37
QUETIAPINE FUMARATE 94 94 26 66
IPRATROPIUM BROMIDE 94 94 26 183
HYDROCHLOROTHIAZIDE 93 92 28 10
ESCITALOPRAM OXALATE 89 88 29 82
FENTANYL 88 88 S2 30 76
OXYCODONE HCL 86 84 S2 31 72
ISOSORBIDE MONONITRATE ER 85 85 32 45
ALENDRONATE SODIUM 77 77 33 26
PREDNISONE 76 74 34 39
MUPIROCIN 76 76 34 180
HYDRALAZINE HCL 75 73 36 104
AMOXICILLIN 70 70 37 107
GABAPENTIN 62 59 38 14
CITALOPRAM HBR 62 62 38 16
LIDODERM 61 61 40 122
LANTUS 61 61 40 47
VANCOMYCIN HCL 60 60 42 398
CARVEDILOL 57 54 43 25
CIPROFLOXACIN HCL 57 57 43 56
TAMSULOSIN HCL 56 56 45 29
METOPROLOL SUCCINATE 55 54 46 19
PRAVASTATIN SODIUM 51 50 47 13
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 25, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.